DNA APTAMERS FOR EOSINOPHIL PEROXIDASE DETECTION

CYSTIC LYMPHANGIOMA TREATMENT DRUG

APTAMERS FOR PERSONAL HEALTH CARE APPLICATIONS

APTAMERS FOR PERSONAL HEALTH CARE APPLICATIONS

DNA POLYMERASE, APTAMER, WARM-START DNA POLYMERASE AND PREPARATION METHODS AND APPLICATION THEREOF

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

ANTI-C5 AGENT FOR TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION (AMD) OR GEOGRAPHIC ATROPHY SECONDARY TO DRY AMD

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

Aptamers Specific for TLR-4 and Uses Thereof

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

Aptamers That Bind Thiamine Analogs and Derivatives

ELECTROCHEMICAL DETECTION NANOSTRUCTURE, SYSTEMS AND USES THEREOF

Nucleic acid oligomers and uses therefor

Blood-Brain Barrier Penetrating Aptamer and Use Thereof

OLIGONUCLEOTIDE PROBES AND USES THEREOF

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

APTAMER FOR IL-21 AND USE THEREOF

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING OCULAR DISEASES

NUCLEIC ACID LIGAND AND USE THEREOF

ANTICANCER APTAMERS AND USES THEREOF

METHODS AND COMPOSITIONS OF RNA NANOSTRUCTURES FOR REPLICATION AND SUB-GENOMIC EXPRESSION BY RNA-DIRECTED RNA POLYMERASE

Peptides for use in immunotherapy against cancers

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

CCR8 peptide and T cells for use in immunotherapeutic treatment of various cancers

NOVEL NUCLEIC ACID LIGAND AND METHOD FOR IDENTIFYING SAME

REGULATION OF GENE EXPRESSION VIA APTAMER-MEDIATED CONTROL OF SELF-CLEAVING RIBOZYMES

DNA-ENCODED FUNCTIONALIZED APTAMERS

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR GENERATING SCAFFOLDS FOR THE USE AGAINST PANCREATIC CANCER AND OTHER CANCERS

DNA NANOARCHITECTURES FOR PATTERN-RECOGNIZED TARGETING OF DISEASES

G-rich iso-RNA oligomers as aptamers

CONVERSION OF STRAND DISPLACEMENT APTAMERS INTO MOLECULAR BEACONS

L-RNA APTAMERS AND METHODS OF IDENTIFYING THE SAME

RNA SCAFFOLDS

MONOCYTE-SPECIFIC APTAMERS AND USES THEREOF FOR ENHANCING DRUG DELIVERY TO CANCER

MONOCYTE-SPECIFIC APTAMERS AND USES THEREOF FOR DELIVERING THERAPEUTIC AGENTS TO HEART

D-DIMER-SPECIFIC APTAMERS AND METHODS OF USE IN DIAGNOSTICS, THERAPEUTIC AND THERANOSTIC PURPOSES

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

METHODS OF REDUCING OR PREVENTING CLOSTRIDIOIDES DIFFICILE COLONIZATION

Nucleic Acid Compounds for Binding Growth Differentiation Factor 11

CYTOTOXIC T-LYMPHOCYTE BINDING APTAMERS

BISPECIFIC PERSONALIZED APTAMERS

Screening artificial nucleic acids by particle display

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

PATHOGEN DETECTION USING APTAMER MOLECULAR PHOTONIC BEACONS

Amphiphilic polynucleotides

COMPLEMENT ANAPHYLATOXIN BINDERS AND THEIR USE IN TREATMENT OF A SUBJECT HAVING AN OCULAR WOUND AND/OR FIBROSIS

Method for treating non-small lung cancer with a population of activated T cells

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

Aptamer-Engineered Natural Killer Cells for Cell-Specific Adaptive Immunotherapy

RNA APTAMERS AND USE THEREOF FOR TREATING CANCER

BIFUNCTIONAL MOLECULES AND METHODS OF USING THEREOF

METHOD FOR SELECTING APTAMERS WITH HIGH TARGET SPECIFICITY IN A MICROFLUIDIC DEVICE PLATFORM FOR CO-CULTURE OF MULTIPLE TISSUES

CIRCULAR BIFUNCTIONAL APTAMERS AND TRIFUNCTIONAL APTAMERS TARGETING Tau

Insulin receptor aptamer and pharmaceutical composition for treating diabetes comprising the same

METHODS AND COMPOSITIONS FOR APTAMER-DRIVEN SURFACE FORMULATION OF SELF-FORMING POLYNUCLEOTIDE NANOPARTICLES

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Method of Modulating the Number and the Distribution of Tumor-Infiltrating Leukocytes in Tumors

RNA TARGETING OF MUTATIONS VIA SUPPRESSOR tRNAs AND DEAMINASES

Oligonucleotides and methods for preparing

GLYPICAN-3-SPECIFIC MODIFIED APTAMER AND USE THEREOF

In immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

METHOD FOR IMPROVING SPECIFICITY AND AFFINITY OF APTAMER BY MOLECULAR DESIGN GUIDANCE

MASKED FLUOROGENIC COMPOUNDS AND METHODS OF USING THE SAME

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

FUNCTIONAL LIGANDS TO TARGET MOLECULES

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

DNA APTAMER SPECIFICALLY BINDING TO GLUTATHIONE AND USE THEREOF

DELIVERY OF COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES

APTAMERS FOR THE REVERSIBLE INHIBITION OF DNA POLYMERASES

END-TO-END APTAMER DEVELOPMENT SYSTEM

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST BREAST CANCER AND OTHER CANCERS

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Aptamers and use thereof

Providing template rooms within a virtual conferencing system

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

Nucleic Acid Compounds for Binding to Complement Component 3 Protein

RNA-GUIDED GENOME RECOMBINEERING AT KILOBASE SCALE

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

DRUG FOR CURATIVE THERAPY OF INTRACTABLE HEREDITARY RENAL ALPORT SYNDROME

High Throughput Cell-Based Screening for Aptamers

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

SWITCHABLE CAS9 NUCLEASES AND USES THEREOF

Thrombin Binding Circular Aptamer and Use Thereof

METHOD AND COMPOSITION FOR MEASUREMENT OF NITRIC OXIDE

ANTI-CANCER IMMUNOTHERAPEUTIC COMPOSITION FOR TREATING CANCER

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

COMPOSITIONS AND METHODS RELATED TO TRANSFERRIN RECEPTOR-BINDING APTAMERS

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

NUCLEIC ACID COMPLEXES FOR SCREENING BARCODED COMPOUNDS

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR GENERATING SCAFFOLDS FOR THE USE AGAINST PANCREATIC CANCER AND OTHER CANCERS

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

A FIBER-OPTIC WAVE GUIDE SENSOR OF APTAMERS AND A DETECTION METHOD OF ITS APPLICATION

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

RAPID AND SPECIFIC EX-VIVO DIAGNOSIS OF CENTRAL NERVOUS SYSTEM LYMPHOMA

REGULATION OF VON WILLEBRAND FACTOR (VWF)

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells

DEVICES, METHODS AND COMPOSITIONS FOR APTAMER SCREENING

Method Of Using Aptamer For Detecting Glycated Hemoglobin In Whole Blood And Nanoelectronic Aptasensor

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

Monocyte and macrophage binding aptamers and their application

AN UBIQUITIN LIGASE INHIBITOR FOR USE FOR PREVENTING AND/OR TREATING A DISEASE LINKED WITH CEREBRAL HYPOPERFUSION

USE OF COMPOSITION FOR ENHANCING ANTICANCER EFFECT, COMPRISING ERRy INHIBITOR AS ACTIVE INGREDIENT

METHODS FOR CONTROLLING EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) COAGULATION

SBE APTAMERS FOR TREATING IL-17a RELATED DISEASES AND CONDITIONS

APTAMER NUCLEIC ACID MOLECULE, AND COMPLEX AND APPLICATION THEREOF

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

DNMT1-Specific Aptamers and Production and Uses Thereof

METHODS FOR DETECTING AN ANALYTE USING STRUCTURE SWITCHING BINDING AGENTS

APTAMER NANOFIBERS AND KILL-SWITCHES AND USES THEREOF

Aptamer-Based Multispecific Therapeutic Agents

Targeting Synaptogyrin-3 in Tauopathy Treatment

FUNCTIONAL LIGANDS TO SARS-COV-2 SPIKE PROTEIN

APTAMERS AGAINST TRANSFERRIN RECEPTOR (TfR)

METHOD FOR PRODUCING NUCLEIC ACID MOLECULE, BIOMATERIAL, AND METHOD FOR PRODUCING BIOMATERIAL

THERMOSTABLE POLYMERASE INHIBITOR COMPOSITIONS AND METHODS

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptides and T cells for use in immunotherapeutic treatment of various cancers

METHODS AND COMPOSITIONS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE

DNA aptamers and use thereof for the treatment of cancer

RNA APTAMER THAT SPECIFICALLY BINDS HISTAMINE

APTAMER BASED SYSTEM TO QUANTIFY ANTI-THROMBIN III IN BLOOD

FPR2 RECEPTOR AGONIST APTAMERS AND USES THEREOF

Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods

COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES WITH MODULAR FUNCTIONALITY

ANTI-C5 AGENT FOR TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION (AMD) OR GEOGRAPHIC ATROPHY SECONDARY TO DRY AMD

CD44 aptamer

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS

Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers

CHIMERIC COMPLEX AND THERAPEUTIC USES THEREOF

Peptides and combination thereof for use in the immunotherapy against cancers

Therapeutic oligonucleotides

Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

BISPECIFIC APTAMER FOR TREATING CANCER

CA-IX APTAMERS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF

L-RNA APTAMER CYCLIZATION AND USE THEREOF

Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Systems and methods for chemical and biological authentication

Tumor cell analysis using aptamers and microfluidic systems

METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER

Nucleic acid aptamer specifically recognizing β-lactoglobulin and use thereof

INHIBITOR AGAINST EXPRESSION OF IMMUNE CHECKPOINT MOLECULE

Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells

Nucleic Acid Compounds that Bind to Retinoic Acid-Inducible Gene I Protein

Compositions and Methods Relating to Synthetic RNA Polynucleotides Created From Synthetic DNA Oligonucleotides

INHIBITION OF MTHFD1L FOR USE IN HYPERTROPHIC HEART DISEASE AND HEART FAILURE

PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS

Tumor-Targeting Polypeptide Nanoparticle Delivery System for Nucleic Acid Therapeutics

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

Peptides and T cells for use in immunotherapeutic treatment of various cancers

APTAMER ASSEMBLIES FOR PROTEIN CROSSLINKING

Use of aptamers in proteomics

Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods

Targeting technology to selectively express mRNAs in cardiomyocytes while avoiding stimulation of cardiac fibroblasts

Peptides and T cells for use in immunotherapeutic treatment of various cancers

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers

Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers

An Aptamer for Dengue Virus and Related Methods and Products

Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers

Aptamers Against Clostridium Difficile

IMMUNOTHERAPY WITH B*07 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS

Aptamer-based sensors for detection of fentanyl opioids

RNA-REGULATED FUSION PROTEINS AND METHODS OF THEIR USE

USE OF MÜLLERIAN INHIBITING SUBSTANCE INHIBITORS FOR TREATING CANCER

METHOD OF DETECTION OF FIBRIN CLOTS

Defined multi-conjugates oligonucleotides

SYSTEM FOR REGULATING GENE EXPRESSION

Highly Efficient DNA Base Editors Mediated By RNA-Aptamer Recruitment For Targeted Genome Modification And Uses Thereof

OLIGONUCLEOTIDE PROBES AND USES THEREOF

Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods

Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods

Targeting ligands for tau pathology

REGULATION OF GENE EXPRESSION BY APTAMER-MEDIATED MODULATION OF ALTERNATIVE SPLICING

APTAMER FOR TGF-BETA1 AND USE OF SAME

Method of promoting a t-cell response or treating cancer by administering an antagonist to human c-type lectin-like receptor-1 (CLEC-1)

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

SPECTRALLY FILTERED PHOTODIODE PAIR

POINT-OF-CARE IMMUNOASSAY FOR QUANTITATIVE SMALL ANALYTE DETECTION

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

METHODS FOR TREATING RAN PROTEIN-ASSOCIATED NEUROLOGICAL DISEASES

CLOSED LOOP CONTINUOUS APTAMER DEVELOPMENT SYSTEM

GOLD NANOPARTICLE-SELEX BASED SCREENING METHOD FOR TARGET-SPECIFIC APTAMERS

Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

COMPOSITIONS AND METHODS FOR HIGH-EFFICIENCY RECOMBINATION OF RNA MOLECULES

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

NOVEL DNA APTAMERS AND USE THEREOF

CIRCULAR RNAS FOR CELLULAR THERAPY

Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

METHOD OF TREATING AGE-RELATED MACULAR DEGENERATION

Anti-CD3 Aptamers for Use in Cell Targeting and Labeling

EPH2A APTAMER AND USES THEREOF

Inhibition of nucleic acid polymerases by endonuclease V-cleavable circular oligonucleotide ligands

Inhibition of DNA polymerases by uracil-DNA glycosylase-cleavable oligonucleotide ligands

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and T cells for use in immunotherapeutic treatment hepatocellular carcinoma

Peptides and T cells for use in immunotherapeutic treatment of various cancers

GINS2 peptide and T cells for use in immunotherapeutic treatment of various cancers

PEPTIDOGLYCAN (PGN) APTAMERS AND ASSOCIATED METHODS

Adeno-Associated Virus Virions with Variant Capsid and Methods of Use Thereof

APTAMERS AGAINST GLIOBLASTOMA

Lipoteichoic acid (LTA) aptamers and associated methods

LIPOPOLYSACCHARIDE (LPS) APTAMERS AND ASSOCIATED METHODS

SCREENING METHOD OF APTAMER AND IMMUNOASSAY USING THE APTAMER

Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers

APTAMER SPECIFICALLY BINDING TO KRAS PROTEIN AND METHOD FOR USING SAME

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

TREATMENT AND PREVENTION OF MALARIA

PEPTIDES AND T CELLS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS

PEPTIDES AND T CELLS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS

USE OF CD9 AS A BIOMARKER AND AS A BIOTARGET IN GLOMERULONEPHRITIS OR GLOMERULOSCLEROSIS

SYSTEMS AND METHODS FOR DETECTING A PATHOGENIC ORGANISM

LINKED BODY FOR FLUORESCENT LABELING AGENTS

Method for treating non-small lung cancer with a population of activated cells

Peptides and T cells for use in immunotherapeutic treatment of various cancers

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CLL AND OTHER CANCERS

Kit for aflatoxin B1 (AFB1) monitoring

Nanoparticle to target cancer

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF

METHODS OF ACHIEVING HIGH SPECIFICITY OF GENOME EDITING

RNA TARGETING OF MUTATIONS VIA SUPPESSOR tRNAs AND DEAMINASES

Compounds for detecting and treating

CD40 Specific DNA Aptamers as Vaccine Adjuvants

T-lymphocyte binding aptamers

Aptamers against , compositions comprising aptamers against and methods of using the same

ANTIBODIES AND ENONOMERS

Peptides and T cells for use in immunotherapeutic treatment of various cancers

Methods for treating or preventing ophthalmological conditions

RIBOSWITCH-BASED FLUORIDE SENSING IN CELL-FREE EXTRACT

OLIGONUCLEOTIDE PROBES AND USES THEREOF

USE OF BIOLOGICAL RNA SCAFFOLDS WITH IN VITRO SELECTION TO GENERATE ROBUST SMALL MOLECULE BINDING APTAMERS FOR GENETICALLY ENCODABLE BIOSENSORS

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

BLOCK COPOLYMERS AND USES THEREOF

NUCLEIC ACID MAZZOCCHIO AND METHODS OF MAKING AND USE THEREOF

NOVEL NUCLEIC ACID MODIFIERS

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptides and T cells for use in immunotherapeutic treatment of various cancers

COMPOSITIONS, METHODS, AND KITS FOR AMPLIFYING NUCLEIC ACIDS

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

CTLA-4 aptamer conjugates

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Nucleic acid aptamer for influenza virus and detection of influenza virus

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

PAPER-BASED LOW-COST MICROFLUIDIC DEVICES FOR AUTOMATIC MULTISTEP PROCESSES

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

METHODS TO DETERMINE WHETHER A SUBJECT IS SUITABLE OF BEING TREATED WITH AN AGONIST OF SOLUBLE GYANYLYL CYCLASE (SGC)

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

Inhibition of nucleic acid polymerases by endonuclease V-cleavable oligonucleotide ligands

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LEUKEMIAS AND OTHER CANCERS

APTAMERS AGAINST IMATINIB

METHODS AND COMPOSITIONS FOR SELECTION OF FUNCTIONAL APTAMERS

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

PHOSPHOR-INTEGRATED NANOPARTICLES FOR TARGET SUBSTANCE DETECTION

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML AND OTHER CANCERS

NOVEL NUCLEIC ACID MODIFIERS

STEM-LOOP COMPOSITIONS AND METHODS FOR INHIBITING VASCULAR ENDOTHELIAL GROWTN FACTOR

Anti-fibrinogen aptamers

NOVEL DNA APTAMER AND USE THEREOF

Method for generating aptamers with improved off-rates

STABILIZED THROMBIN

COMPOSITIONS AND METHODS RELATING TO C5L2

Aptamers and use thereof

APTAMER AND USE OF THE APTAMER IN THE DIAGNOSIS AND TREATMENT OF CANCER

DNA APTAMERS SPECIFIC OF ADENOVIRUS TYPES

THERAPEUTIC OLIGONUCLEOTIDES

Bi specific aptamer

INHIBITORS OF SARM1 IN COMBINATION WITH NAD+ OR A NAD+ PRECURSOR

X-aptamers for the use in detection of SNAP25

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers